153 related articles for article (PubMed ID: 19138959)
21. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic identification and quantification of aberrant crypt foci in the human colon.
Adler DG; Gostout CJ; Sorbi D; Burgart LJ; Wang L; Harmsen WS
Gastrointest Endosc; 2002 Nov; 56(5):657-62. PubMed ID: 12397272
[TBL] [Abstract][Full Text] [Related]
23. Risks and benefits of celecoxib to prevent recurrent adenomas.
Psaty BM; Potter JD
N Engl J Med; 2006 Aug; 355(9):950-2. PubMed ID: 16943408
[No Abstract] [Full Text] [Related]
24. Aberrant crypt foci: what we know and what we need to know.
Gupta AK; Pretlow TP; Schoen RE
Clin Gastroenterol Hepatol; 2007 May; 5(5):526-33. PubMed ID: 17433788
[TBL] [Abstract][Full Text] [Related]
25. A further piece of the puzzle: positive FOBT, colonoscopy, aspirin and the prevention of colorectal cancer.
Ockenga J
Digestion; 2012; 85(4):276-7. PubMed ID: 22538259
[No Abstract] [Full Text] [Related]
26. Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.
Bertagnolli MM; Hsu M; Hawk ET; Eagle CJ; Zauber AG;
Cancer Prev Res (Phila); 2010 May; 3(5):588-96. PubMed ID: 20403998
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
[TBL] [Abstract][Full Text] [Related]
28. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease.
Nascimbeni R; Villanacci V; Mariani PP; Di Betta E; Ghirardi M; Donato F; Salerni B
Am J Surg Pathol; 1999 Oct; 23(10):1256-63. PubMed ID: 10524527
[TBL] [Abstract][Full Text] [Related]
29. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
Clapper ML; Chang WL; Cooper HS
Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
[TBL] [Abstract][Full Text] [Related]
30. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis.
Hurlstone DP; Cross SS
J Gastroenterol Hepatol; 2005 Feb; 20(2):173-81. PubMed ID: 15683417
[TBL] [Abstract][Full Text] [Related]
31. A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions.
Wirth LJ; Krane JF; Li Y; Othus M; Moran AE; Dorfman DM; Norris CM; Goguen L; Posner MR; Haddad RI; Bertagnolli MM
Cancer Prev Res (Phila); 2008 Oct; 1(5):339-48. PubMed ID: 19138978
[TBL] [Abstract][Full Text] [Related]
32. K-ras and p53 mutations in human colorectal aberrant crypt foci.
Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
[TBL] [Abstract][Full Text] [Related]
33. Early detection and prevention of colorectal cancer (review).
Dashwood RH
Oncol Rep; 1999; 6(2):277-81. PubMed ID: 10022989
[TBL] [Abstract][Full Text] [Related]
34. [New tests for the prevention of colorectal cancer].
Herzog J; Eickhoff A; Riemann JF
Dtsch Med Wochenschr; 2012 Sep; 137(37):1814-7. PubMed ID: 22956226
[No Abstract] [Full Text] [Related]
35. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
Manzano A; Pérez-Segura P
ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
[TBL] [Abstract][Full Text] [Related]
36. [Genetics and molecular classification of colorectal cancer].
Søreide K
Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2818-23. PubMed ID: 17987073
[TBL] [Abstract][Full Text] [Related]
37. [Large colorectal adenomas].
Mäkelä J; Riekkinen N; Rotko N; Laitinen S
Duodecim; 2002; 118(22):2318-22. PubMed ID: 12523109
[No Abstract] [Full Text] [Related]
38. Aberrant crypt foci.
Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
[TBL] [Abstract][Full Text] [Related]
39. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
[TBL] [Abstract][Full Text] [Related]
40. European initiatives in colorectal cancer screening.
O'Morain CA; Van Cutsem E; Spicak J; Classen M; Faulds Wood L; Stockbrugger R
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):201-3. PubMed ID: 21304316
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
